BioCatalystWatch
AIMDWorkspace / AIMD / OverviewCompany library
Price
Market cap
Next catalystmid-2026VELDONA® · Data readoutCompany source ↗
Cash

Chart & Events

Candle interval

Core Clinical

VELDONA®

Upcoming / outlook

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

VELDONA®

Upcoming / outlook

Other pipelines

VELDONA®

Upcoming / outlook

VELDONA®

Partner / License out

VELDONA®

Upcoming / outlook

Approved / commercial

SARS-CoV-2 antigen

Approved

PreINDP1P2P3FilingApproved

History / paused

VELDONA®

PreINDP1P2P3FilingApproved
VELDONA®

Financial position

Short-term investments

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Source and basis

Source and basis

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

AIMD PR & News

PR & News

AIMD SEC archive